A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 154 participants.
Also called NCT05326230
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 154 participants
- Sponsor
- Otsuka Medical Devices Co., Ltd. Japan
- Registry
-
NCT05326230
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05326230. Randomized; double masking; primary purpose treatment. Start 2022-07-01 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)
- Condition
- Hypertension
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- Paradise™ (PRDS-001) Renal Denervation Ultrasound System
- Intervention (Device)
- Renal Angiogram
- Lead sponsor
- Otsuka Medical Devices Co., Ltd. Japan
Record details
- Record id
cardio:ct-nct05326230- Content hash
e0696de5e9ae81997e115ea4122156a3d0c43b33a5b30224780fa22abfc7fe1d